Results 171 to 180 of about 35,632 (212)

Extracorporeal membrane oxygenation (ECMO) as lung or heart assist

Acta Anaesthesiologica Scandinavica, 1996
Extracorporeal membrane oxygenation (ECMO) may serve as extracorporeal lung assist (ECLA) in patients with acute respiratory failure (ARF) or as extracorporeal heart assist (ECHA) in patients with low output syndrome (LOS) after open heart surgery. From 1988 to 1992 seven patients underwent ECMO in our hospital; four suffered from ARF and three from ...
L, Bjertnaes, J, Vaage, S M, Almdahl, M, Lie, P A, Nilsen, K, Hansen, J, Solbø, A, Jolin, R, Hotvedt, K, Olafsen, A, Bröndbo, J, Thoner, M, Gilbert, O, Hevrøy, G, Bjørsvik, N, Hesselberg, H, Bergland, O, Sivertsen   +17 more
openaire   +2 more sources

Patient Complications During Extracorporeal Membrane Oxygenation (ECMO)

European Journal of Pediatric Surgery, 1991
Extracorporeal membrane oxygenation (ECMO) has rapidly become the treatment of choice for critically ill newborns with reversible pulmonary disease not responding to conventional treatment. Since 1987 ECMO has been available at our hospital and up to December 1989 11 patients were treated. Several patient complications were seen.
B, Frenckner, H, Ehrén, K, Palmér
openaire   +2 more sources

Follow-up in Neonatal Extracorporeal Membrane Oxygenation (ECMO)

The International Journal of Artificial Organs, 1995
In 34 survivors of the first 43 ECMO patients from our institution before discharge to another hospital or home an EEG, BAER, Head Ultrasonography, cerebral CT scan, Dubowitz score and ophthalmological inspection were performed. At one year of age Mental Developmental Index of the Bayley scales, Motor Quotient as well as pulmonary and neurological ...
W B, Geven, L A, Nabuurs-Korhman, J M, Van Kessel-Feddema, C, Festen   +3 more
openaire   +2 more sources

Coagulation activation during extracorporeal membrane oxygenation (ECMO)

Thrombosis Research, 2022
Extracorporeal membrane oxygenation (ECMO) can be life-saving, but suffers from thrombus formation in the circuit with associated risks of oxygenator occlusion, hemolysis and arterial embolism. The formation of thrombin is the key step to thrombus formation and two factors are needed for sustained thrombin generation, a coagulation activator to ...
openaire   +2 more sources

Extracorporeal Membrane Oxygenation (ECMO) for Neonatal Respiratory Failure

The Thoracic and Cardiovascular Surgeon, 1992
Extracorporeal membrane oxygenation (ECMO) has been a successful treatment (82% survival) in over 5000 neonates with severe respiratory failure (80% predicted mortality without ECMO). ECMO is prolonged extracorporeal cardiopulmonary bypass achieved by extrathoracic vascular cannulation using a modified heart-lung machine.
J B, Zwischenberger, C S, Cox
openaire   +2 more sources

An overview of extracorporeal membrane oxygenation (ECMO)

Paediatrics and Child Health, 2011
Abstract Extracorporeal membrane oxygenation is used for unresponsive cardiorespiratory failure in neonates, children and adults. There is good evidence of its efficacy in neonates and adults and as such it is reasonable that children are referred for ECMO when faced with severe cardiorespiratory failure.
openaire   +1 more source

Pharmacotherapy in Neonatal and Pediatric Extracorporeal Membrane Oxygenation (ECMO)

Current Drug Metabolism, 2012
ECMO support is an established life saving therapy for potentially reversible respiratory and/or cardiac failure. Improvement of outcome depends on effective treatment of the primary diagnosis and complications. Adequate drug therapy is important in reaching these goals.
Wildschut, E.D., Ahsman, Maurice, Houmes, Robert jan, Pokorna, P, de Wildt, Saskia, Mathot, RAA, Tibboel, Dick   +6 more
openaire   +3 more sources

Extracorporeal membrane oxygenation (ECMO) during pregnancy and postpartum

Seminars in Perinatology, 2018
Extracorporeal membrane oxygenation (ECMO) can provide respiratory support (VV-ECMO) or both respiratory and circulatory support (VA-ECMO). The use of ECMO has increased dramatically as a result of simpler technology. No level I evidence is yet available reflecting improved outcomes with ECMO.
Luis D, Pacheco, George R, Saade, Gary D V, Hankins   +2 more
openaire   +2 more sources

Obesity and Extracorporeal Membrane Oxygenation (ECMO): Analysis of Outcomes

Journal of Cardiothoracic and Vascular Anesthesia
Traditionally, patients with obesity have been deemed ineligible for extracorporeal life support (ELS) therapies such as extracorporeal membrane oxygenation (ECMO), given the association of obesity with chronic health conditions that contribute to increased morbidity and mortality.
Juan G. Ripoll, Mariam ElSaban, Christoph S. Nabzdyk, Aditi Balakrishna, Mauricio A. Villavicencio, Rolando D. Calderon-Rojas, Jamel Ortoleva, Marvin G. Chang, Edward A. Bittner, Harish Ramakrishna   +9 more
openaire   +2 more sources

Extracorporeal Membrane Oxygenation (ECMO) – Time is of the Essence!

Heart, Lung and Circulation, 2021
Jaishankar, Raman, Steven C, Musca, Yvette L, O'Brien   +2 more
openaire   +2 more sources